Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-((4-trifluoromethyl)phenyl)-1,2-dihydroquinoline-3-carboxamide
2. Abr-215050
1. 254964-60-8
2. Abr-215050
3. Tasquinimod [inn]
4. 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[4-(trifluoromethyl)phenyl]quinoline-3-carboxamide
5. 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-(4-(trifluoromethyl)-phenyl)-1,2-dihydroquinoline-3-carboxamide
6. 756u07kn1r
7. 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-((4-trifluoromethyl)phenyl)-1,2-dihydroquinoline-3-carboxamide
8. 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-(4-(trifluoromethyl)phenyl)-1,2-dihydroquinoline-3-carboxamide
9. Unii-756u07kn1r
10. Tasq
11. 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[4-(trifluoromethyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
12. Tasquinimod [mi]
13. Tasquinimod [who-dd]
14. Tasquinimod(abr-215050)
15. Gtpl8098
16. Schembl4476895
17. Chembl2107784
18. Dtxsid90180183
19. Zinc602397
20. Bcp10352
21. Bdbm50565139
22. Mfcd18251454
23. S7617
24. Am84841
25. Ccg-268712
26. Cs-0898
27. Db05861
28. Sb16938
29. Ncgc00379032-04
30. Ac-32481
31. As-35208
32. Hy-10528
33. Ds-001403
34. A911276
35. Q7687612
36. 1,2-dihydro-4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[4-(trifluoromethyl)phenyl]-3-quinolinecarboxamide
37. 4-hydroxy-5-methoxy-n-methyl-1-methyl-2-oxo-n-(4-trifluoromethylphenyl)-1,2-dihydroquinoline-3-carboxamide
38. 4-hydroxy-n-[4-(trifluoromethyl)phenyl]-5-methoxy-n,1-dimethyl-2-oxo-1,2-dihydroquinoline-3-carboxamide
39. N-methyl-n-(4-trifluoromethyl-phenyl)-1,2-dihydro-4-hydroxy-5-methoxy-1-methyl-2-oxo-quinoline-3-carboxamide
Molecular Weight | 406.4 g/mol |
---|---|
Molecular Formula | C20H17F3N2O4 |
XLogP3 | 3.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 3 |
Exact Mass | 406.11404151 g/mol |
Monoisotopic Mass | 406.11404151 g/mol |
Topological Polar Surface Area | 70.1 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 686 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in prostate cancer.
ABOUT THIS PAGE
22
PharmaCompass offers a list of Tasquinimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tasquinimod manufacturer or Tasquinimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tasquinimod manufacturer or Tasquinimod supplier.
PharmaCompass also assists you with knowing the Tasquinimod API Price utilized in the formulation of products. Tasquinimod API Price is not always fixed or binding as the Tasquinimod Price is obtained through a variety of data sources. The Tasquinimod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tasquinimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tasquinimod, including repackagers and relabelers. The FDA regulates Tasquinimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tasquinimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tasquinimod supplier is an individual or a company that provides Tasquinimod active pharmaceutical ingredient (API) or Tasquinimod finished formulations upon request. The Tasquinimod suppliers may include Tasquinimod API manufacturers, exporters, distributors and traders.
click here to find a list of Tasquinimod suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tasquinimod DMF (Drug Master File) is a document detailing the whole manufacturing process of Tasquinimod active pharmaceutical ingredient (API) in detail. Different forms of Tasquinimod DMFs exist exist since differing nations have different regulations, such as Tasquinimod USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tasquinimod DMF submitted to regulatory agencies in the US is known as a USDMF. Tasquinimod USDMF includes data on Tasquinimod's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tasquinimod USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tasquinimod suppliers with USDMF on PharmaCompass.
Tasquinimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tasquinimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tasquinimod GMP manufacturer or Tasquinimod GMP API supplier for your needs.
A Tasquinimod CoA (Certificate of Analysis) is a formal document that attests to Tasquinimod's compliance with Tasquinimod specifications and serves as a tool for batch-level quality control.
Tasquinimod CoA mostly includes findings from lab analyses of a specific batch. For each Tasquinimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tasquinimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Tasquinimod EP), Tasquinimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tasquinimod USP).